{"url_path":"/sec/imvt/10-k/2026/item-16","section_key":"item-16","section_title":"Item 16 Form 10-K Summary","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","accession_number":"0001764013-26-000064","cik":"0001764013","ticker":"IMVT","issuer_name":"Immunovant, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","primary_entity_key":"0001764013","primary_entity_name":"Immunovant, Inc."},"word_count":364,"has_tables":true,"body_markdown":"Item 16. Form 10-K Summary\n\nNone.\n\n148\n\n[Table of Contents](#iffdf096b0e874ebba3b8e07ac3efab3a_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nDate: May 20, 2026\n\nIMMUNOVANT, INC.\n\nBy:\n/s/ Eric Venker\n\nEric Venker, M.D., Pharm. D.\n\nChief Executive Officer\n\nPOWER OF ATTORNEY\n\nKNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Eric Venker, M.D., Pharm. D. and Tiago Girao, and each one of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in their name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.\n\nPursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.\n\nSIGNATURETITLEDATE\n\n/s/ Eric Venker\nChief Executive Officer and DirectorMay 20, 2026\n\nEric Venker, M.D., Pharm. D.\n\n(Principal Executive Officer)\n\n/s/ Tiago Girao\nChief Financial OfficerMay 20, 2026\n\nTiago Girao\n(Principal Financial and Accounting Officer)\n\n/s/ Frank M. TortiExecutive Chairperson of the Board of DirectorsMay 20, 2026\n\nFrank M. Torti, M.D.\n\n/s/ Jacob Bauer\nDirectorMay 20, 2026\n\nJacob Bauer\n\n/s/ Andrew FromkinDirectorMay 20, 2026\n\nAndrew Fromkin\n\n/s/ Douglas HughesDirectorMay 20, 2026\n\nDouglas Hughes\n\n/s/ Atul PandeDirectorMay 20, 2026\n\nAtul Pande, M.D.\n\n/s/ Robert Susman\nDirectorMay 20, 2026\n\nRobert Susman\n\n149"}